SCHEMBL28825199

SCHEMBL28825199

COc1cc(Cl)cc([N+](=O)[O-])c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 3/20 0.46
KDM4E B2RXH2 3/20 0.45
MAPT P10636 3/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX15 P16050 1/20 0.45
PRKDC P78527 1/20 0.45
HSD17B10 Q99714 1/20 0.45
LMNA P02545 3/20 0.44
MEN1 O00255 1/20 0.44
ALOX12 P18054 1/20 0.44
KMT2A Q03164 1/20 0.44
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.41
S1PR4 O95977 1/20 0.41
CYP1A2 P05177 1/20 0.41
DHODH Q02127 1/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10983620 0.84 ALDH1A1 (0.47) ALDH1A1TDP1KDM4EMAPTCYP3A4
SCHEMBL3612247 0.82 TDP1 (0.54) ALDH1A1TDP1MAPTCYP3A4HSD17B10
SCHEMBL12776990 0.81 MAPK1 (0.53) ALDH1A1TDP1KDM4EMAPTCYP3A4
SCHEMBL25329734 0.81 ALDH1A1 (0.44) ALDH1A1TDP1KDM4EMAPTCYP3A4
SCHEMBL4018068 0.81 KDM4E (0.47) ALDH1A1TDP1KDM4EMAPTCYP3A4
SCHEMBL6010819 0.81 EGFR (0.54) TDP1MAPTLMNAMEN1KMT2A
SCHEMBL2591957 0.80 MAPK1 (0.50) ALDH1A1TDP1KDM4EMAPTCYP3A4
SCHEMBL1494444 0.79 CYP1A2 (0.49) ALDH1A1TDP1KDM4EMAPTCYP3A4
SCHEMBL3921406 0.79 ALDH1A1 (0.49) ALDH1A1TDP1KDM4EMAPTCYP3A4
SCHEMBL31423166 0.79 CYP1A2 (0.49) ALDH1A1TDP1KDM4EMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105121430-A Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases GLAXO GROUP LTD 2015-12-02 CN disclosed